2nd Quarter - Report
W STRATEGIES, LLC for ABBOTT LABORATORIES
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 5651: Food and Drug Administration Reform Act of 2012, S. 3187: Food and Drug Administration Safety and Innovation Act of 2012, as it relates to provisions affecting drug and medical device approval process. Federal legislative efforts to enhance the security and integrity of the domestic pharmaceutical distribution system.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.